Literature DB >> 7401243

Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications.

J G Blaivas, K B Labib, S J Michalik, A A Zayed.   

Abstract

We studied 42 patients with urinary incontinence who demonstrated uninhibited detrusor contractions during cystometry. Each patient underwent urodynamic evaluation before and after the parenteral administration of propantheline bromide. Of these 42 patients 33 (79 per cent) had a positive response to propantheline: total abolition of uninhibited bladder contractions or 200 per cent increase in bladder capacity. Of these 33 patients 26 were treated with the oral drug and all but 1 had complete clinical response. Urinary retention occurred in half of the patients. These patients were managed with intermittent self-catheterization in addition to oral propantheline. None of the patients who failed to respond to the parenteral medication had a favorable response to the orally administered drug.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7401243     DOI: 10.1016/s0022-5347(17)55398-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Multiple Sclerosis: Symptomatic Treatment.

Authors:  C T Bever
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

3.  A critical reappraisal of cystometry in neurogenic bladder diseases.

Authors:  T Petersen; M Hedegaard
Journal:  Urol Res       Date:  1987

4.  A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.

Authors:  T Petersen; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

Review 5.  The lower urinary tract.

Authors:  J M Robinson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 6.  Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis)

Authors:  C J Fowler; P E van Kerrebroeck; A Nordenbo; H Van Poppel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 7.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

8.  Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample.

Authors:  Susan A Hall; Carol L Link; Jim C Hu; Paul W Eggers; John B McKinlay
Journal:  BJU Int       Date:  2009-06-22       Impact factor: 5.588

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.